A

ALXN

Alexion Pharm Inc

Performance

Today’s LowNA
    Today’s HighNA
    52W LowNA
      52W HighNA
      Open PricePrev. CloseVolumeAvg. Volume
      NANANANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $27.18 B2.6032.10$26.96 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA47.56-4.84NA

      About the Company

      Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood di
      Organisation
      Alexion Pharm Inc
      Industry
      Biotechnology
      Headquarters
      Boston, MA
      ABOUT GROWW
      keyboard_arrow_down